Anaptysbio (ANAB) Return on Equity (2017 - 2025)
Historic Return on Equity for Anaptysbio (ANAB) over the last 9 years, with Q3 2025 value amounting to 2.28%.
- Anaptysbio's Return on Equity rose 58000.0% to 2.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.28%, marking a year-over-year increase of 58000.0%. This contributed to the annual value of 1.83% for FY2024, which is 8900.0% down from last year.
- Anaptysbio's Return on Equity amounted to 2.28% in Q3 2025, which was up 58000.0% from 24.76% recorded in Q2 2025.
- Anaptysbio's Return on Equity's 5-year high stood at 24.76% during Q2 2025, with a 5-year trough of 5.9% in Q2 2024.
- For the 5-year period, Anaptysbio's Return on Equity averaged around 0.28%, with its median value being 0.4% (2022).
- Per our database at Business Quant, Anaptysbio's Return on Equity crashed by -51400bps in 2024 and then soared by 306600bps in 2025.
- Quarter analysis of 5 years shows Anaptysbio's Return on Equity stood at 0.15% in 2021, then plummeted by -162bps to 0.4% in 2022, then crashed by -283bps to 1.53% in 2023, then fell by -22bps to 1.87% in 2024, then skyrocketed by 222bps to 2.28% in 2025.
- Its last three reported values are 2.28% in Q3 2025, 24.76% for Q2 2025, and 2.68% during Q1 2025.